156 related articles for article (PubMed ID: 33552934)
1. Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
Barros JM; Rizzo MM; Chiozza JO; Couñago F
World J Clin Oncol; 2021 Jan; 12(1):1-5. PubMed ID: 33552934
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Killingberg KT; Halvorsen TO; Fløtten Ø; Brustugun OT; Langer SW; Nyman J; Hornslien K; Madebo T; Schytte T; Risum S; Tsakonas G; Engleson J; Grønberg BH
Lung Cancer; 2022 Apr; 166():49-57. PubMed ID: 35183991
[TBL] [Abstract][Full Text] [Related]
3. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
4. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
5. Thoracic Radiotherapy in Limited-Stage SCLC-a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018.
Graabak G; Grønberg BH; Sandvei MS; Nilssen Y; Halvorsen TO
JTO Clin Res Rep; 2022 Feb; 3(2):100270. PubMed ID: 35146461
[TBL] [Abstract][Full Text] [Related]
6. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.
Luan Z; Wang Z; Huang W; Zhang J; Dong W; Zhang W; Li B; Zhou T; Li H; Zhang Z; Wang Z; Sun H; Yi Y
Exp Ther Med; 2015 Aug; 10(2):671-678. PubMed ID: 26622373
[TBL] [Abstract][Full Text] [Related]
8. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.
Takada M; Fukuoka M; Kawahara M; Sugiura T; Yokoyama A; Yokota S; Nishiwaki Y; Watanabe K; Noda K; Tamura T; Fukuda H; Saijo N
J Clin Oncol; 2002 Jul; 20(14):3054-60. PubMed ID: 12118018
[TBL] [Abstract][Full Text] [Related]
9. Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy.
Jeong JU; Jeon W; Ahn SJ; Kim YC; Oh IJ; Park CK; Yoon MS; Song JY; Nam TK; Chung WK
Oncol Lett; 2020 Jan; 19(1):239-246. PubMed ID: 31897135
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
[TBL] [Abstract][Full Text] [Related]
11. Limited-stage small-cell lung cancer: the current status of combined-modality therapy.
Socinski MA; Bogart JA
J Clin Oncol; 2007 Sep; 25(26):4137-45. PubMed ID: 17827464
[TBL] [Abstract][Full Text] [Related]
12. Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.
Viani GA; Gouveia AG; Matsuura FK; Jacinto AA; Moraes FY
Radiother Oncol; 2022 Aug; 173():41-48. PubMed ID: 35101470
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
Saito H; Takada Y; Ichinose Y; Eguchi K; Kudoh S; Matsui K; Nakagawa K; Takada M; Negoro S; Tamura K; Ando M; Tada T; Fukuoka M;
J Clin Oncol; 2006 Nov; 24(33):5247-52. PubMed ID: 17114657
[TBL] [Abstract][Full Text] [Related]
14. Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis.
Qi J; Xu L; Sun J; Wang X; Zhao L
Cancer Manag Res; 2019; 11():10767-10775. PubMed ID: 31920386
[TBL] [Abstract][Full Text] [Related]
15. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
[TBL] [Abstract][Full Text] [Related]
16. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
17. Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.
Zahra A; Chang T; Hejleh TA; Furqan M; Clamon GH; Bhatia SK; Watkins JM; Mott SL; Ahmann LL; Bodeker KL; Spitz DR; Buatti JM; Allen BG
J Oncol Transl Res; 2016 Nov; 2(1):. PubMed ID: 27981260
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
[TBL] [Abstract][Full Text] [Related]
19. Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2019 Jan; 20(1):13-19. PubMed ID: 30219240
[TBL] [Abstract][Full Text] [Related]
20. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis.
Kim BH; Song C; Kim HJ
Radiother Oncol; 2023 Jul; 184():109696. PubMed ID: 37150449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
